nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cancer is not just a disease of a tissue: It is a host disease
|
Apetoh, L. |
|
2008 |
69 |
2 |
p. 151-152 2 p. |
artikel |
2 |
Éditorial
|
Touraine, Philippe |
|
2008 |
69 |
2 |
p. 97-98 2 p. |
artikel |
3 |
Editorial Board
|
|
|
2008 |
69 |
2 |
p. ii- 1 p. |
artikel |
4 |
Endocytosis of sex steroids: The hypothesis of free hormones revisited
|
Willnow, T.E. |
|
2008 |
69 |
2 |
p. 101-102 2 p. |
artikel |
5 |
Environment and endocrinology: The case of thyroidology
|
Köhrle, J. |
|
2008 |
69 |
2 |
p. 116-122 7 p. |
artikel |
6 |
How the new tools to analyze the human genome are opening new perspectives: The use of gene expression in investigations of the adrenal cortex
|
Stratakis, C.A. |
|
2008 |
69 |
2 |
p. 123-129 7 p. |
artikel |
7 |
Les cibles hormonales de la réponse auto-immune
|
Geenen, V. |
|
2008 |
69 |
2 |
p. 107-111 5 p. |
artikel |
8 |
Le traitement du diabète par les cellules souches
|
Heinis, M. |
|
2008 |
69 |
2 |
p. 143-146 4 p. |
artikel |
9 |
Molecular diagnosis of differentiated thyroid cancer. Towards the application in clinical practice
|
Rousset, B. |
|
2008 |
69 |
2 |
p. 135-137 3 p. |
artikel |
10 |
Métabolisme intestinal et contrôle de l’appétit : du gène à la pathologie
|
Mithieux, G. |
|
2008 |
69 |
2 |
p. 112-115 4 p. |
artikel |
11 |
Neuroendocrinology: Past, present and future
|
Guillemin, R. |
|
2008 |
69 |
2 |
p. 160- 1 p. |
artikel |
12 |
New immunomodulators in the treatment of Graves’ ophthalmopathy
|
Salvi, M. |
|
2008 |
69 |
2 |
p. 153-156 4 p. |
artikel |
13 |
New peptide-based therapies for metabolic diseases
|
Culler, M.D. |
|
2008 |
69 |
2 |
p. 161- 1 p. |
artikel |
14 |
New treatments of diabetes: The β-amylin agonists
|
Lebovitz, H.E. |
|
2008 |
69 |
2 |
p. 147-150 4 p. |
artikel |
15 |
Nuclear receptors and human disease: Resistance to thyroid hormone and lipodystrophic insulin resistance
|
Chatterjee, V.K.K. |
|
2008 |
69 |
2 |
p. 103-106 4 p. |
artikel |
16 |
Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001)
|
Schmid, H.A. |
|
2008 |
69 |
2 |
p. 162-163 2 p. |
artikel |
17 |
Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010
|
Werner, U. |
|
2008 |
69 |
2 |
p. 164-165 2 p. |
artikel |
18 |
The future of diabetes treatment
|
Petersen, J.S. |
|
2008 |
69 |
2 |
p. 166-167 2 p. |
artikel |
19 |
Thyroid hormone analogues: Useful biological probes and potential therapeutic agents
|
Scanlan, T.S. |
|
2008 |
69 |
2 |
p. 157-159 3 p. |
artikel |
20 |
Transcriptome analysis of endocrine tumors: Clinical perspectives
|
Giordano, T.J. |
|
2008 |
69 |
2 |
p. 130-134 5 p. |
artikel |
21 |
Une vue protéomique des tumeurs endocrines
|
Diaz, J.-J. |
|
2008 |
69 |
2 |
p. 138-142 5 p. |
artikel |